NBT Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.3K | Buy |
138
+12
| +10% | +$2.21K | ﹤0.01% | 573 |
|
|
2025
Q4 | $22.2K | Sell |
126
-108
| -46% | -$17.6K | ﹤0.01% | 593 |
|
|
2025
Q3 | $32.8K | Sell |
234
-50
| -18% | -$6.76K | ﹤0.01% | 545 |
|
|
2025
Q2 | $35.7K | Buy |
284
+35
| +14% | +$4.36K | ﹤0.01% | 535 |
|
|
2025
Q1 | $34.1K | Sell |
249
-441
| -64% | -$63K | ﹤0.01% | 528 |
|
|
2024
Q4 | $106K | Buy |
690
+25
| +4% | +$4.22K | 0.01% | 419 |
|
|
2024
Q3 | $129K | Buy |
+665
| New | +$139K | 0.01% | 412 |
|
|
2023
Q3 | – | Sell |
-829
| Closed | -$236K | – | 313 |
|
|
2023
Q2 | $236K | Buy |
829
+54
| +7% | +$16.1K | 0.03% | 237 |
|
|
2023
Q1 | $215K | Sell |
775
-129
| -14% | -$35.7K | 0.03% | 241 |
|
|
2022
Q4 | $250K | Hold |
904
| – | – | 0.04% | 222 |
|
|
2022
Q3 | $241K | Buy |
+904
| New | +$192K | 0.04% | 207 |
|
|
2021
Q4 | – | Sell |
-905
| Closed | -$256K | – | 248 |
|
|
2021
Q3 | $256K | Sell |
905
-25
| -3% | -$8.19K | 0.04% | 220 |
|
|
2021
Q2 | $322K | Hold |
930
| – | – | 0.04% | 200 |
|
|
2021
Q1 | $260K | Buy |
930
+40
| +4% | +$10.8K | 0.04% | 208 |
|
|
2020
Q4 | $218K | Buy |
+890
| New | +$230K | 0.03% | 214 |
|
|
2020
Q2 | – | Sell |
-769
| Closed | -$243K | – | 213 |
|
|
2020
Q1 | $243K | Buy |
769
+80
| +12% | +$24.3K | 0.05% | 185 |
|
|
2019
Q4 | $205K | Buy |
+689
| New | +$191K | 0.03% | 219 |
|
|
2019
Q3 | – | Sell |
-879
| Closed | -$205K | – | 191 |
|
|
2019
Q2 | $205K | Hold |
879
| – | – | 0.04% | 184 |
|
|
2019
Q1 | $208K | Sell |
879
-180
| -17% | -$56.7K | 0.04% | 178 |
|
|
2018
Q4 | $319K | Sell |
1,059
-104
| -9% | -$33.2K | 0.05% | 163 |
|
|
2018
Q3 | $411K | Hold |
1,163
| – | – | 0.07% | 152 |
|
|
2018
Q2 | $337K | Hold |
1,163
| – | – | 0.06% | 155 |
|
|
2018
Q1 | $319K | Sell |
1,163
-3,492
| -75% | -$1.08M | 0.05% | 164 |
|
|
2017
Q4 | $1.48M | Sell |
4,655
-214
| -4% | -$68.7K | 0.23% | 99 |
|
|
2017
Q3 | $1.52M | Buy |
4,869
+4,050
| +495% | +$1.2M | 0.24% | 99 |
|
|
2017
Q2 | $222K | Hold |
819
| – | – | 0.04% | 190 |
|
|
2017
Q1 | $224K | Buy |
819
+40
| +5% | +$11.3K | 0.04% | 195 |
|
|
2016
Q4 | $221K | Buy |
779
+20
| +3% | +$5.93K | 0.04% | 190 |
|
|
2016
Q3 | $237K | Buy |
+759
| New | +$225K | 0.04% | 189 |
|
Other funds holding BIIB
VCM
VPM
NBT Bank's BIIB Position: Q1 2026 in Review
NBT Bank increased its Biogen (BIIB) stake by 9.5% in Q1 2026, buying an estimated $2.21K and bringing the position to 138 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #573.
NBT Bank first reported a position in BIIB in Q3 2016 and has held it in 29 quarters since. The position peaked at $1.52M in Q3 2017. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- NBT Bank held 138 shares of Biogen worth $25.3K as of Q1 2026.
- NBT Bank bought 12 Biogen shares in Q1 2026, an estimated $2.21K.
- Biogen made up ﹤0.01% of NBT Bank's portfolio in Q1 2026, its #573 holding.
- NBT Bank first reported a position in Biogen in Q3 2016 and has held it in 29 quarters since.
- NBT Bank's Biogen position peaked at $1.52M in Q3 2017.
- 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.